跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-10
首页
药物
M-10
M-10
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ATOVAQUONE WITH A PARTICLE SIZE DIAMETER RANGE (D90) OF GREATER THAN 3 MICRONS TO ABOUT 10 MICRONS
申请人: ALPHAPHARM PTY LTD
优先权: 2008
CN
US
2 件公开
Suzuki coupling method of B (9, 10)-site o-dibromo substituted m-carborane and application
申请人: UNIV EAST CHINA SCIENCE & TECH
优先权: 2024
CN
Applications of spiro piperazine quaternary ammonium salt compound LXM-10-M in preparation of anti-inflammatory drugs
申请人: UNIV BEIJING
优先权: 2014
CN
CANCER CELL-INHIBITING CERAMIC, PROCESS FOR PRODUCING CANCER CELL-INHIBITING CERAMIC, METHOD FOR TREATING BONE TUMOR, AND USE OF BETA-TRICALCIUM PHOSPHATE POROUS GRANULES WITH PARTICLE SIZE OF 1 TO 10 MICROMETER
申请人: OLYMPUS CORP
优先权: 2011
CN
US
2 件公开
Conjugate-based antifungal and antibacterial prodrugs
申请人: BAPAT ABHIJIT S
优先权: 2012
CN
US
3 件公开
Pharmaceutical composition
申请人: VIIV HEALTHCARE UK III LTD
优先权: 2023
CN
8-hydroxyquinoline functionalized tripod hydrazide gel factor as well as synthesis and application thereof
申请人: UNIV NORTHWEST NORMAL
优先权: 2024
CN
Patch Material
申请人: NICHIBAN KK
优先权: 2007
CN
US
3 件公开
药物
反馈